Proteomics and irritable bowel syndrome

被引:5
作者
Tsigaridas, Athanasios [1 ]
Papanikolaou, Ioannis S. [2 ,3 ]
Vaiopoulou, Anna [4 ]
Anagnostopoulos, Athanasios K. [5 ]
Viazis, Nikos [1 ]
Karamanolis, George [6 ]
Karamanolis, Dimitrios G. [1 ]
Tsangaris, George T. [5 ]
Mantzaris, Gerasimos J. [1 ]
Gazouli, Maria [4 ]
机构
[1] Evangelismos Med Ctr, Gastroenterol Unit, Athens, Greece
[2] Univ Athens, Hepatogastroenterol Unit, Dept Internal Med 2, Athens, Greece
[3] Univ Athens, Med Sch, Res Inst, Attikon Univ,Gen Hosp, Athens, Greece
[4] Univ Athens, Dept Basic Med Sci, Lab Biol, Med Sch, Michalakopoulou 176, Athens 11527, Greece
[5] Acad Athens IIBEAA, Biomed Res Fdn, Prote Res Unit, Athens, Greece
[6] Univ Athens, Aretaieio Univ Hosp, Gastroenterol Unit, Dept Surg 2,Med Sch, Athens, Greece
关键词
Genetics; IBS; pathophysiology; proteomics; biomarkers; VISCERAL HYPERSENSITIVITY; COLONIC HYPERMOTILITY; SYNDROME IBS; PROTEIN; BIOMARKERS; ACTIVATION; REVEALS; INTERLEUKIN-6; EPIDEMIOLOGY; PATHOGENESIS;
D O I
10.1080/14789450.2017.1317600
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Irritable bowel syndrome (IBS) is a gastrointestinal disease that according to Rome IV criteria is subdivided into four subtypes. The pathophysiology of this disease is not well understood due to numerous factors playing multiple roles in disease development, such as diet, stress and hormones. IBS has a variety of symptoms and overlaps with many other gastrointestinal and non-gastrointestinal diseases.Area covered: This review aims to present an overview of implementation of proteomics in experimental studies in the field of IBS.Expert commentary: Proteomics is commonly used for biomarker discovery in and has also been extensively used in IBS research. The necessity of a sensitive and specific biomarker for IBS is apparent, but despite the intensive research performed in this field, an appropriate biomarker is not yet available.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 90 条
[1]   Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome [J].
Aerssens, Jeroen ;
Camilleri, Michael ;
Talloen, Willem ;
Thielemans, Leen ;
Goehlmann, Hinrich W. H. ;
Van den Wyngaert, Ilse ;
Thielemans, Theo ;
De Hoogt, Ronald ;
Andrews, Christopher N. ;
Bharucha, Adil E. ;
Carlson, Paula J. ;
Busciglio, Irene ;
Burton, Duane D. ;
Smyrk, Thomas ;
Urrutia, Raul ;
Coulie, Bernard .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (02) :194-205
[2]  
Ahmed IM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077869, 10.1371/journal.pone.0058204]
[3]   Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain [J].
Akbar, A. ;
Yiangou, Y. ;
Facer, P. ;
Walters, J. R. F. ;
Anand, P. ;
Ghosh, S. .
GUT, 2008, 57 (07) :923-929
[4]   Irritable Bowel Syndrome-The Main Recommendations [J].
Andresen, Viola ;
Keller, Jutta ;
Pehl, Christian ;
Schemann, Michael ;
Preiss, Jan ;
Layer, Peter .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (44) :751-U25
[5]   Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis - A Pilot Study [J].
Arasaradnam, Ramesh P. ;
Westenbrink, Eric ;
McFarlane, Michael J. ;
Harbord, Ruth ;
Chambers, Samantha ;
O'Connell, Nicola ;
Bailey, Catherine ;
Nwokolo, Chuka U. ;
Bardhan, Karna D. ;
Savage, Richard ;
Covington, James A. .
PLOS ONE, 2014, 9 (10)
[6]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[7]  
Bai T, 2016, J GASTROENTEROL HEPA
[8]   Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS [J].
Banik, Gourab Dutta ;
De, Anulekha ;
Som, Suman ;
Jana, Subhra ;
Daschakraborty, Sunil B. ;
Chaudhuri, Sujit ;
Pradhan, Manik .
JOURNAL OF BREATH RESEARCH, 2016, 10 (02)
[9]   Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? [J].
Barrett, Jacqueline S. ;
Gibson, Peter R. .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (04) :261-268
[10]   New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome [J].
Barshop, Kenneth ;
Staller, Kyle .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7 :E146